
    
      Each subject will undergo a total of 9 visits. Subjects' eligibility will be assessed at
      Screening, which can occur up to 28 days prior to dosing. Following a repeat eligibility
      check at Day 0, eligible subjects will be randomized and dosed with the randomized treatment
      (BPL HRIG + vaccine or Comparator HRIG + vaccine) on Day 0. Further assessments will be
      conducted on Days 3, 5, 7, 14, 28, 49 and the end of study assessment on Day 140. Vaccine
      will be administered on Day 0, 3, 7, 14 and 28.
    
  